Faith Gibson (right) has won a $6.2 million class-action settlement from the makers of Paxil

Surrey woman part of $6.2-million Paxil award

Faith Gibson takes GlaxoSmithKline to task over the prescription medication for anxiety and depression she took while pregnant.

After nine years fighting a drug company over her daughter’s heart defect, a Surrey mom is part of a group receiving a $6.2-million settlement.

During her pregnancy, Faith Gibson was taking Paxil, a drug for anxiety and depression manufactured by GlaxoSmithKline.

When her daughter Meah Bartram was born, she had a hole in her heart.

Meah was born in September of 2005, the same month that GlaxoSmithKline issued a warning that the drug might cause “congenital malformations… most commonly cardiovascular” in babies. The most common problem was a hole in the heart.

Paxil has been manufactured since the early 1990s. It is in a class of a drugs known as selective serotonin reuptake inhibitors (SSRIs).

Health Canada and its U.S. counterpart issued warnings about the potential hazard Paxil poses to the unborn.

Meah is now 11 years old and by all appearances is doing fine.

“She’s doing okay,” Gibson told The Leader in an interview Wednesday. “I guess the hard thing with stuff is anytime… she runs, or has a pain in her chest, or has cramps, she feels like there’s something wrong with her heart.”

There were times during her eight-year legal battle when Gibson felt discouraged, but she never gave up her resolve.

“The whole time I’m like, ‘no, I want to see this all the way through, I don’t care how long it takes’,” Gibson said.

As part of the settlement, GlaxoSmithKline agreed to pay $6.2 million to the fewer than 50 people in the class action lawsuit against the drug company.

Once the settlement is distributed, Gibson said she’ll put the money in a trust fund for her daughter.

Vancouver lawyer David Rosenberg told The Leader it was a tough battle, particularly getting class action certification, a move that was won and then appealed.

The case was scheduled for a full trial in January when the parties settled on the eve of proceedings getting underway.

“It was quite a complicated and difficult case,” Rosenberg said, adding one of the strongest parts of his case was the “very significant consequences” some of the new mothers and their babies faced.

“It’s heartbreaking,” he said.

GlaxoSmithKline (GSK) has not admitted to, nor has it been found, responsible for Paxil causing the heart defects.

“GSK does not admit to any liability or wrongdoing as part of the proposed settlement, but has agreed to resolve the class action to avoid the time and expense associated with the trial and the subsequent steps in the class action proceeding,” a representative from GlaxoSmithKline said in an email to The Leader.

GlaxoSmithKline said customer safety continues to be its highest aim.

“We continue to be of the view that the scientific evidence does not establish that exposure to Paxil during pregnancy causes cardiovascular birth defects,” the company spokesperson said. “Patient safety is our highest concern and we continue to believe that the company provided accurate and updated information in relation to Paxil to regulators, and communicated important safety information to regulatory agencies, the scientific community and healthcare professionals.”

Any women who took Paxil during their pregnancy and have a child with defects, particularly in the heart, are asked to email david@rosenberglaw.ca to share in the award.

The deadline to become part of the settlement is March 26 at 5 p.m.

 

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Comments are closed

Just Posted

B.C.’s major rivers surge, sparking flood warnings

A persistent low pressure system over Alberta has led to several days of heavy rain

Tourism Chilliwack rolls out mobile visitors’ centre in an RV called Winston

Part of an innovative recovery plan following the hit local tourism has taken from COVID-19

Search continues for person seen floating in Coquihalla River in Hope

Rescuers halted the search Thursday night as darkness fell

Missing Chilliwack woman has not been in contact with family for several months

The RCMP are asking for the public’s help in locating 35-year-old Chantelle Chenier of Chilliwack

Rescuers halt Coquihalla River search due to darkness, after reports of person in river

No information to indicate a child is involved, RCMP state, after this information surfaced on social media

13 new B.C. COVID-19 cases, Langley Lodge outbreak ends

Health care outbreaks down to four, 162 cases active

Greater Vancouver home sales start to tick up, with prices holding steady

Residential sales last month reached 2,443, a 64.5 per cent jump from May

Langley Lodge’s deadly outbreak declared over

Fraser Health and long-term care home administrator confirm Friday declaration

PHOTOS: South Surrey tractor project evokes ‘$1-million smile,’ helps connect neighbours

Retired Surrey firefighter Ron Henze began project for friend’s dad to fill time during pandemic

Alberta health minister orders review into response after noose found in hospital in 2016

A piece of rope tied into a noose was found taped to the door of an operating room at the Grande Prairie Hospital in 2016

B.C.’s Indigenous rights law faces 2020 implementation deadline

Pipeline projects carry on as B.C. works on UN goals

‘Mind boggling’: B.C. man $1 million richer after winning Lotto 6/49 a second time

David O’Brien hopes to use his winnings to travel and of course keep playing the lottery

B.C. teacher loses licence after sexual relationships with two recently-graduated students

The teacher won’t be allowed to apply for a teaching certificate until 2035

Most Read